Skip to content
  • Tuesday, 25 August 2026
  • 1:07 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities
Pharmaceutical R&D

Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities

Teuku Ryan Jul 21, 2026 0

Samsung Biologics has announced its intent to acquire PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specializing in…

Read More
Laboratory Automation & Robotics

CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division

Lana Keisha Jul 18, 2026 0

AustinPx, a Contract Development and Manufacturing Organization (CDMO) based in Texas, has forged an exclusive agreement with Thermo Fisher Scientific’s…

Read More
Laboratory Automation & Robotics

CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division

Lana Keisha Jul 10, 2026 0

AustinPx, a Texas-based Contract Development and Manufacturing Organization (CDMO) specializing in bioavailability enhancement, has forged an exclusive agreement with Thermo…

Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?Stanford Researchers Engineer Cephalopod-Inspired Soft Material Capable of Dynamic Nanoscale Texture and Color TransformationHow to tackle the unique pharmacokinetic properties of covalent drugs
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ